Combining radiotherapy and immunotherapy: A revived partnership

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 3, 2005, Pages 655-666

  Demaria, Sandra ^a   Bhardwaj, Nina ^a   McBride, William H ^b   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cross priming; Immunotherapy; Ionizing radiation; Tumor associated antigens

Indexed keywords

ANTIGENS; CELLS; IMMUNOLOGY; IONIZING RADIATION; TUMORS;

CANCER CELLS; CROSS-PRIMING; CYTOTOXIC EFFECTS;

RADIOTHERAPY;

ADENOVIRUS VECTOR; CANCER VACCINE; CYTOKINE; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADVANCED CANCER; ANTIGEN PRESENTATION; CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CPG ISLAND; DENDRITIC CELL; FOWLPOX VIRUS; GENETIC ASSOCIATION; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOTHERAPY; REVIEW; SYSTEMIC DISEASE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; VACCINATION; VACCINIA VIRUS; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 25844459044     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.06.032     Document Type: Article

References (128)

1. W.H. McBride, C.-S. Chiang, J.L. Olson A sense of danger from radiation Radiat Res 162 2004 1 19
2. E.J. Friedman Immune modulation by ionizing radiation and its implications for cancer immunotherapy Curr Pharm Des 8 2002 1765 1780
3. P. Ehrlich Ueber den jetzigen stand der Karzinomforschung Ned Tijdschr Geneeskd 5 1909 273 290
4. C. Yee, S.R. Riddell, P.D. Greenberg In vivo tracking of tumor-specific T cells Curr Opin Immunol 13 2001 141 146
5. G.P. Dunn, A.T. Bruce, H. Ikeda Cancer immunoediting From immunosurveillance to tumor escape Nat Immunol 3 2002 991 998
6. M.T. Spiotto, Y.X. Fu, H. Schreiber Tumor immunity meets autoimmunity Antigen levels and dendritic cell maturation Curr Opin Immunol 15 2003 725 730
7. T. Wolfel, M. Hauer, J. Schneider A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science 269 1995 1281 1284
8. R.E. Clark, I.A. Dodi, S.C. Hill Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL β3α2 fusion protein Blood 98 2001 2887 2893
9. O.J. Finn, K.R. Jerome, R.A. Henderson MUC-1 epithelial tumor mucin-based immunity and cancer vaccines Immunol Rev 145 1995 61 89
10. K.Y. Tsang, S. Zaremba, C.A. Nieroda Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine J Natl Cancer Inst 87 1995 982 990
11. M. Theobald, J. Biggs, D. Dittmer Targeting p53 as a general tumor antigen Proc Natl Acad Sci U S A 92 1995 11993 11997
12. C.G. Ioannides, B. Fisk, D. Fan Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene Cell Immunol 151 1993 225 234
13. M.J. Scanlan, A.O. Gure, A.A. Jungbluth Cancer/testis antigens An expanding family of targets for cancer immunotherapy Immunol Rev 188 2002 22 32
14. V.H. Engelhard, T.N. Bullock, T.A. Colella Antigens derived from melanocyte differentiation proteins Self-tolerance, autoimmunity, and use for cancer immunotherapy Immunol Rev 188 2002 136 146
15. A. Heiser, D. Coleman, J. Dannull Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors J Clin Invest 109 2002 409 417
16. J. Konya, J. Dillner Immunity to oncogenic human papillomaviruses Adv Cancer Res 82 2001 205 238
17. C.M. Rooney, C.A. Smith, C.Y. Ng Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 92 1998 1549 1555
18. D.W. O'Neill, S. Adams, N. Bhardwaj Manipulating dendritic cell biology for the active immunotherapy of cancer Blood 104 2004 2235 2246
19. P. Matzinger Tolerance, danger, and the extended family Annu Rev Immunol 12 1994 991 1045
20. M. Skoberne, A.S. Beignon, N. Bhardwaj Danger signals A time and space continuum Trends Mol Med 10 2004 251 257
21. E. Kopp, R. Medzhitov Recognition of microbial infection by Toll-like receptors Curr Opin Immunol 15 2003 396 401
22. J.W. Yewdell, C.C. Norbury, J.R. Bennink Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo Implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines Adv Immunol 73 1999 1 77
23. L.A. Harshyne, S.C. Watkins, A. Gambotto Dendritic cells acquire antigens from live cells for cross-presentation to CTL J Immunol 166 2001 3717 3723
24. F.P. Huang, N. Platt, M. Wykes A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes J Exp Med 191 2000 435 444
25. S. Hugues, E. Mougneau, W. Ferlin Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells Immunity 16 2002 169 181
26. K.L. Rock, A. Hearn, C.J. Chen Natural endogenous adjuvants Springer Semin Immunopathol 26 2005 231 246
27. M. Li, G.M. Davey, R.M. Sutherland Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo J Immunol 166 2001 6099 6103
28. P. Rovere, C. Vallinoto, A. Bondanza Cutting edge Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function J Immunol 161 1998 4467 4471
29. B. Sauter, M.L. Albert, L. Francisco Consequences of cell death Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells J Exp Med 191 2000 423 433
30. S. Gallucci, M. Lolkema, P. Matzinger Natural adjuvants Endogenous activators of dendritic cells Nat Med 5 1999 1249 1255
31. Y. Shi, W. Zheng, K.L. Rock Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses Proc Natl Acad Sci U S A 97 2000 14590 14595
32. A. Ronchetti, P. Rovere, G. Iezzi Immunogenicity of apoptotic cells in vivo Role of antigen load, antigen-presenting cells, and cytokines J Immunol 163 1999 130 136
33. Y. Kotera, K. Shimizu, J.J. Mule Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization Cancer Res 61 2001 8105 8109
34. A.K. Nowak, R.A. Lake, A.L. Marzo Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells J Immunol 170 2003 4905 4913
35. S. Demaria, F.R. Santori, B. Ng Select forms of tumor cell apoptosis induce dendritic cell maturation J Leukoc Biol 77 2005 361 368
36. K.W. Kim, S.H. Kim, J.G. Shin Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity Int J Cancer 109 2004 685 690
37. M. Larsson, J.F. Fonteneau, S. Somersan Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells Eur J Immunol 31 2001 3432 3442
38. Y. Shi, J.E. Evans, K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
39. S.T. Smiley, J.A. King, W.W. Hancock Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4 J Immunol 167 2001 2887 2894
40. C. Termeer, F. Benedix, J. Sleeman Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4 J Exp Med 195 2002 99 111
41. Y. Okamura, M. Watari, E.S. Jerud The extra domain A of fibronectin activates Toll-like receptor 4 J Biol Chem 276 2001 10229 10233
42. L. Shen, K.L. Rock Cellular protein is the source of cross-priming antigen in vivo Proc Natl Acad Sci U S A 101 2004 3035 3040
43. J. Neijssen, C. Herberts, J.W. Drijfhout Cross-presentation by intercellular peptide transfer through gap junctions Nature 434 2005 83 88
44. R.M. Steinman, M.C. Nussenzweig Avoiding horror autotoxicus The importance of dendritic cells in peripheral T cell tolerance Proc Natl Acad Sci U S A 99 2002 351 358
45. L. Milas, K.A. Mason, H. Ariga CpG oligodeoxynucleotide enhances tumor response to radiation Cancer Res 64 2004 5074 5077
46. C. Vogel, M.A. Cobleigh, D. Tripathy First-line, single-agent Herceptin (trastuzumab) in metastatic breast cancer A preliminary report Eur J Cancer 37 Suppl. 1 2001 S25 S29
47. J.N. Blattman, P.D. Greenberg Cancer immunotherapy A treatment for the masses Science 305 2004 200 205
48. K.L. Rock, A.L. Goldberg Degradation of cell proteins and the generation of MHC class I-presented peptides Annu Rev Immunol 17 1999 739 779
49. C. Watts The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules Nat Immunol 5 2004 685 692
50. C.J.M. Melief Tumor eradication by adoptive transfer of cytotoxic T lymphocytes Adv Cancer Res 58 1992 143 175
51. F. Ossendorp, E. Mengede, M. Camps Specific T helper cell requirement for optimal induction of cytotoxic class II negative tumors J Exp Med 187 1998 693 702
52. N.J. Waterhouse, J.A. Trapani CTL Caspases terminate life, but that's not the whole story Tissue Antigens 59 2002 175 183
53. C. Yee, J.A. Thompson, P. Roche Melanocyte destruction after antigen-specific immunotherapy of melanoma Direct evidence of T cell-mediated vitiligo J Exp Med 192 2000 1637 1644
54. D. Hawiger, K. Inaba, Y. Dorsett Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo J Exp Med 194 2001 769 779
55. M.V. Dhodapkar, R.M. Steinman, J. Krasovsky Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells J Exp Med 193 2001 233 238
56. D.I. Gabrilovich, H.L. Chen, K.R. Girgis Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 2 1996 1096 1103
57. D.I. Gabrilovich, J. Corak, I.F. Ciernik Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 3 1997 483 490
58. S. Kusmartsev, D.I. Gabrilovich Immature myeloid cells and cancer-associated immune suppression Cancer Immunol Immunother 51 2002 293 298
59. J. Shimizu, S. Yamazaki, S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells A common basis between tumor immunity and autoimmunity J Immunol 163 1999 5211 5218
60. S. Onizuka, I. Tawara, J. Shimizu Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor-α) monoclonal antibody Cancer Res 59 1999 3128 3133
61. R.P. Sutmuller, L.M. van Duivenvoorde, A. van Elsas Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses J Exp Med 194 2001 823 832
62. J.G. Egen, M.S. Kuhns, J.P. Allison CTLA-4 New insights into its biological function and use in tumor immunotherapy Nat Immunol 3 2002 611 618
63. D. Leach, M. Krummel, J.P. Allison Enhancement of anti-tumor immunity by CTLA4-blockade Science 271 1996 1734 1736
64. Y.-F. Yang, J.-P. Zou, J. Mu Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade The effect is manifested only at the restricted tumor-bearing stages Cancer Res 57 1997 4036 4041
65. D. Watters Molecular mechanisms of ionizing radiation-induced apoptosis Immunol Cell Biol 77 1999 263 271
66. M. Larsson, J.F. Fonteneau, N. Bhardwaj Dendritic cells resurrect antigens from dead cells Trends Immunol 22 2001 141 148
67. P.K. Chakravarty, A. Alfieri, E.K. Thomas Flt3-Ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer Cancer Res 59 1999 6028 6032
68. E.Y. Nikitina, D.I. Gabrilovich Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice Approach to treatment of advanced stage cancer Int J Cancer 94 2001 825 833
69. S. Demaria, B. Ng, M.-L. Devitt Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated Int J Radiat Oncol Biol Phys 58 2004 862 870
70. H. Ishihara, K. Tsuneoka, A.B. Dimchev Induction of the expression of the interleukin-1 beta gene in mouse spleen by ionizing radiation Radiat Res 133 1993 321 326
71. D.E. Hallahan, D.R. Spriggs, M.A. Beckett Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation Proc Natl Acad Sci U S A 86 1989 10104 10107
72. J.H. Hong, C.S. Chiang, I.L. Campbell Induction of acute phase gene expression by brain irradiation Int J Radiat Oncol Biol Phys 33 1995 619 626
73. J.H. Hong, C.S. Chiang, C.Y. Tsao Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation Int J Radiat Biol 75 1999 1421 1427
74. C. Rieser, G. Bock, H. Klocker Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells Synergistic activation of interleukin 12 production J Exp Med 186 1997 1603 1608
75. K.K. Steinauer, I. Gibbs, S. Ning Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells Int J Radiat Oncol Biol Phys 48 2000 325 328
76. Y.P. Liao, C.C. Wang, L.H. Butterfield Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells J Immunol 173 2004 2462 2469
77. M.A. Sheard, B. Vojtesek, L. Janakova Up-regulation of Fas (CD95) in human p53 wild-type cancer cells treated with ionizing radiation Int J Cancer 73 1997 757 762
78. M.A. Sheard Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis Int J Cancer 96 2001 213 220
79. B. Klein, D. Loven, H. Lurie The effect of irradiation on expression of HLA class I antigens in human brain tumors in culture J Neurosurg 80 1994 1074 1077
80. A.D. Santin, J.C. Hiserodt, J. Fruehauf Effects of irradiation on the expression of surface antigens in human ovarian cancer Gynecol Oncol 60 1996 468 474
81. R. Vereecque, G. Buffenoir, R. Gonzalez Gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells Br J Haematol 108 2000 825 831
82. M. Chakraborty, S.I. Abrams, K. Camphausen Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy J. Immunol 170 2003 6338 6347
83. C.T. Garnett, C. Palena, M. Chakarborty Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes Cancer Res 64 2004 7985 7994
84. M. Chakraborty, S.I. Abrams, C.N. Coleman External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing Cancer Res 64 2004 4328 4337
85. R. Ganss, E. Ryschich, E. Klar Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication Cancer Res 62 2002 1462 1470
86. P.C. Brooks, J.M. Roth, S.C. Lymberis Ionizing radiation modulates the exposure of the HUIV26 cryptic epitope within collagen type IV during angiogenesis Int J Radiat Oncol Biol Phys 54 2002 1194 1201
87. D. Hallahan, J. Kuchibhotla, C. Wyble Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium Cancer Res 56 1996 5150 5155
88. D.E. Hallahan, S. Virudachalam Accumulation of P-selectin in the lumen of irradiated blood vessels Radiat Res 152 1999 6 13
89. E. Ryschich, W. Harms, T. Loeffler Radiation-induced leukocyte adhesion to endothelium in normal pancreas and in pancreatic carcinoma of the rat Int J Cancer 105 2003 506 511
90. D. Hallahan, L. Geng, S. Qu Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels Cancer Cell 3 2003 63 74
91. D.E. Hallahan, M.J. Staba-Hogan, S. Virudachalam X-ray-induced P-selectin localization to the lumen of tumor blood vessels Cancer Res 58 1998 5216 5220
92. K. Tanigawa, N. Takeshita, R.A. Craig Tumor-specific responses in lymph nodes draining murine sarcomas are concentrated in cells expressing P-selectin binding sites J Immunol 167 2001 3089 3098
93. S. Antonia, J.J. Mule, J.S. Weber Current developments of immunotherapy in the clinic Curr Opin Immunol 16 2004 130 136
94. R.B. Cameron, P.J. Spiess, S.A. Rosenberg Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action J Exp Med 171 1990 249 263
95. M. Eder, G. Geissler, A. Ganser IL-3 in the clinic Stem Cells 15 1997 327 333
96. C.S. Chiang, R.G. Syljuasen, J.H. Hong Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo Cancer Res 57 1997 3899 3903
97. Y.T. Oh, D.W. Chen, G.J. Dougherty Adenoviral interleukin-3 gene-radiation therapy for prostate cancer in mouse model Int J Radiat Oncol Biol Phys 59 2004 579 583
98. C.S. Chiang, J.H. Hong, Y.C. Wu Combining radiation therapy with interleukin-3 gene immunotherapy Cancer Gene Ther 7 2000 1172 1178
99. G. Trinchieri Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat Rev Immunol 3 2003 133 146
100. S. Seetharam, M.J. Staba, L.P. Schumm Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation Int J Oncol 15 1999 769 773
101. F. Lohr, K. Hu, Z. Haroon Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy Mol Ther 2 2000 195 203
102. B.J. Sugarman, B.B. Aggarwal, P.E. Hass Recombinant human tumor necrosis factor-alpha Effects on proliferation of normal and transformed cells in vitro Science 230 1985 943 945
103. H. Gerlach, H. Lieberman, R. Bach Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin J Exp Med 170 1989 913 931
104. R.R. Weichselbaum, D.E. Hallahan, M.A. Beckett Gene therapy targeted by radiation preferentially radiosensitizes tumor cells Cancer Res 54 1994 4266 4269
105. R.R. Weichselbaum, D.W. Kufe, S. Hellman Radiation-induced tumour necrosis factor-alpha expression Clinical application of transcriptional and physical targeting of gene therapy Lancet Oncol 3 2002 665 671
106. E. Maraskovsky, K. Brasel, M. Teepe Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice Multiple dendritic cell subpopulations identified J Exp Med 184 1996 1953 1962
107. D.H. Lynch, A. Andreasen, E. Maraskovsky Flt3 ligand induces tumor regression and anti-tumor immune responses in vivo Nat Med 3 1997 625 631
108. S. Teitz-Tennenbaum, Q. Li, S. Rynkiewicz Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration Cancer Res 63 2003 8466 8475
109. M.R. Graf, R.M. Prins, W.T. Hawkins Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination Cancer Immunol Immunother 51 2002 179 189
110. K. Lumniczky, S. Desaknai, L. Mangel Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model Cancer Gene Ther 9 2002 44 52
111. A.M. Krieg Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides Curr Oncol Rep 6 2004 88 95
112. K.A. Mason, H. Ariga, R. Neal Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy Clin Cancer Res 11 2001 361 369
113. Z. Yu, N.P. Restifo Cancer vaccines Progress reveals new complexities J Clin Invest 110 2002 289 294
114. A.A. Hurwitz, T.F.-Y. Yu, D.R. Leach CTLA-4 blockade synergize with tumor-derived granulocyte-macrophage colony stimulating-factor for treatment of an experimental mammary carcinoma Proc Natl Acad Sci U S A 95 1998 10067 10071
115. A. van Elsas, A.A. Hurwitz, J.P. Allison Combination immunotherapy of B16 melanoma using anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation J Exp Med 190 1999 355 366
116. A.A. Hurwitz, B.A. Foster, E.D. Kwon Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade Cancer Res 60 2000 2444 2448
117. S. Demaria, N. Kawashima, A.M. Yang Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer Clin Cancer Res 11 2005 728 734
118. D.E. Hallahan, E.E. Vokes, S.J. Rubin Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy Cancer J Sci Am 1 1995 204 209
119. H.S. Rasmussen, C.S. Rasmussen, M. Lempicki TNFerade biologic Preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene Cancer Gene Ther 9 2002 951 957
120. N. Senzer, S. Mani, A. Rosemurgy TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene A phase I study in patients with solid tumors J Clin Oncol 22 2004 592 601
121. A. Kianmanesh, N.R. Hackett, J.M. Lee Intratumoral administration of low dose of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity Hum Gene Ther 12 2001 2035 2049
122. J.L. Gulley, P.M. Arlen, N. Bastian Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer Clin Cancer Res 11 2005 3353 3362
123. C. Lurquin, B. Lethe, E. De Plaen Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen J Exp Med 201 2005 249 257
124. H.H. Steiner, M.M. Bonsanto, P. Beckhove Antitumor vaccination of patients with glioblastoma multiforme A pilot study to assess feasibility, safety, and clinical benefit J Clin Oncol 22 2004 4272 4281
125. R.K. Ramanathan, K.M. Lee, J. McKolanis Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer Cancer Immunol Immunother 54 2005 254 264
126. G.Q. Phan, J.C. Yang, R.M. Sherry Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc Natl Acad Sci U S A 100 2003 8372 8377
127. F.S. Hodi, M.C. Mihm, R.J. Soiffer Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Proc Natl Acad Sci U S A 100 2003 4712 4717
128. L. Novellino, C. Castelli, G. Parmiani A listing of human tumor antigens recognized by T cells March 2004 update Cancer Immunol Immunother 54 2005 187 207